The story has been updated to include comments by a Biosearch official about LightSpeed's next-gen sequencing development efforts.

NEW YORK (GenomeWeb News) – Biosearch Technologies today announced it has acquired a majority stake in LightSpeed Genomics for an undisclosed amount.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.